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ABSTRACT
Background: Indoor dampness has consistently been associated with respiratory symptoms and
exacerbations. The causal mechanisms may involve increased microbial exposures. However, the
evidence regarding the influence of indoor microbial exposures under damp- and non-damp
conditions on the risk of asthma and allergy has been inconclusive.
Objective: The aim of this study was to investigate the association between dampness and
microbial exposure with allergy and respiratory health in Danish adults using a cross-sectional
design.
Methods: From 1,866 participants of the Health2006 cohort, we selected three non-overlapping
groups: 196 at random, 107 with confirmed atopy, and 99 without atopy. Bedroom dust was
sampled using electrostatic dust fall collectors and analysed for endotoxin, β-(1,3)-D-glucan, 19
microbial species or groups, and total fungal load. Household moisture-related problems and
asthma were self-reported by questionnaire. Atopy was determined by skin-prick-testing and
lung function was measured by spirometry.
Results: Household moisture damage was positively associated with asthma outcomes, although
this was statistically significant only in atopics for self-reported asthma (odds ratio (OR) 3.52; 95%
CI 1.01–12.7). Mould odor was positively associated with wheezing (OR 6.05; 95%CI 1.19–30.7) in
atopics. Inconsistent associations were found for individual microbial exposures and health out-
comes. Inverse associations were observed between microbial diversity and rhinitis in the random
sample and both doctor-diagnosed and self-reported asthma in non-atopics.
Conclusions: In conclusion, our findings suggest that household moisture damage may increase
the risk of asthma and wheeze with mould odor in atopics. In addition, asthma and allergy may
be affected by the indoor microbial composition in urban domestic environments. Further studies
are needed to identify and understand the causal agents and underlying mechanisms behind the
potential effects of environmental microbial exposure on human health.
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Introduction
The prevalence of household dampness in European
dwellings has been estimated to be around 15% [1] and
reports for Danish residences have estimated the pre-
valence of self-reported dampness problems to be: 11%
(1995); 8% (1997); 9% (1999); 11% (2000) [2]. Indoor
dampness has consistently been associated with
respiratory symptoms and exacerbations, and there is
some evidence for association with new-onset asthma
and allergies [3–7] and a stronger negative health effect
of household dampness in atopics [1]. The causal
mechanisms may involve increased microbial expo-
sures, but the evidence is inconclusive.
To date, most epidemiological studies have been lim-
ited to assessing health effects associated with exposure to
microbial components, especially endotoxin, and cultur-
able moulds [8]. The results have been inconsistent, sug-
gesting protective, detrimental, and no health effects in
relation to asthma and allergy [8]. However, comparisons
between studies have been hampered by the lack of
standardization and validation of methods for measuring
indoor microbial exposure. Recently, the use of molecular
techniques such as quantitative polymerase chain reaction
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(qPCR) to identify specific viable and non-viable bacterial
and fungal agents to assess indoor exposure has become
more common. Although some associations between sin-
gle microbial markers and asthma outcomes have been
demonstrated, there are only a few studies using qPCR
and these have largely focused on respiratory health
effects in children [9–13]. Nonetheless, due to the high
sensitivity and reproducibility of qPCR, this method has
been recommended for epidemiological investigations to
assess the role of individual species or genera in the
development and expression in respiratory and allergic
diseases [14–17].
Besides focusing on individual microorganisms,
there is also an interest in the potential effect of quan-
tity and diversity of microbial exposure on respiratory
health. Greater diversity of fungal and bacterial agents
has been shown to reduce the risk of asthma in chil-
dren living on farms [18]. Similarly, one study found
an inverse association between total fungal DNA and
wheeze and nighttime cough in Spanish school chil-
dren [19]. In contrast, another study found a positive
association between elevated levels of total viable
mould and risk of rhinitis and night cough and persis-
tent cough [12], whereas others found no associations
between total fungal DNA and respiratory health out-
comes [11]. These studies highlight the need to study
both the potential effect of individual microbial expo-
sures and quantity and diversity of these exposures.
Therefore, the aim of our study was to evaluate the
prevalence of dampness and microbial exposure in
urban homes and assess their association with allergy
and respiratory health in adult residents. We also
assessed whether health effects associated with damp-
ness and microbial exposure were different for atopics
and non-atopics as atopics may be more susceptible.
Material and methods
Study design and study population
This was a cross-sectional study nested within the
Health2006 cohort. The baseline Health2006 cohort
was randomly drawn from the urban background
population aged 18–69 years, living in 11 municipa-
lities in the south-west of suburban Copenhagen [20].
A total of 3,471 individuals (45%) entered the study
and underwent health examination at the Research
Centre for Prevention and Health (Glostrup
University Hospital, Copenhagen) between 2006 and
2008. In 2011–2012, the baseline Health2006 cohort
was invited for a 5-year follow-up examination fol-
lowing essentially the same study protocol [21]. A
total of 3,405 were eligible for a follow-up invitation
and of these, 2,308 (69%) were reexamined between
November 2011 and November 2012. Of those, 1,866
participants completed questionnaires on their home
indoor environment and consented to collection of
settled dust from their bedroom. For this study, we
selected three distinct groups. We extracted a random
sample of 196 participants reflecting the 5-year fol-
low-up population of the Health2006 cohort. For
investigation of potential different reactions related
to atopic status, we added two groups in the age-
range 30 to 50 years; a random group of 107 partici-
pants with atopy (described below) and a group of 99
non-atopic participants. The design and selection of
participants is illustrated in Figure 1. The study was
approved by the Ethical Committee of the Capital
Region of Denmark (H-3-2011-080) and by the
Danish Data Protection Agency (2006-53-1283).
Participants had received written, oral and video
information about the project and provided written
consent prior to participation.
Exposure assessment
Household dampness and other indoor environment
characteristics
Dampness was determined based on self-reports to yes/
no-questions of four dampness indicators: (1) Have you
noticed any damp stains on surfaces, i.e. floor, walls or
ceiling in your bedroom? (damp stains in bedroom); (2) Is
there any odor of moisture or mould in your home?
(mould odor); (3) Is there any condensation on the inside
of your windows? (condensation on windows); and (4)
Have you ever had moisture damage in your home?
(moisture damage). Additionally, participants reported
the following information: hours spend in the home
during one weekday, type of dwelling (apartment,
detached house, attached house, other type of dwelling),
crowding (occupants per square meter), pet keeping
(yes/no), and smoking (daily, occasionally, ex-smoker,
never smoker).
Dust sampling, extraction and analysis
Detailed information on dust sampling, extraction and
analysis is provided in the supplementary information.
Briefly, settled house dust was collected by participants
using an electrostatic dust fall collector (EDC) (Zeeman,
Utrecht, the Netherlands) placed 1.5 m above the floor in
the participant’s bedroom during a 14-day period [22].
The EDC was returned in an envelope to Aarhus
University and no later than 1 day after receipt, electro-
static cloths were stored at −20°C until undergoing
extraction for dust and bio-aerosols in a sterile liquid
solution as described by Noss et al. [22].
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Two microbial components, endotoxin and β-(1,3)-
D-glucan, were quantified using the Limulus
Amebocyte Lysate (LAL) assay. The detection limits
(LOD) were 9.6 EU/m2 for endotoxin and 366 µg/m2
for β-(1,3)-D-glucan. Among samples, 13% were below
detection limit for endotoxin and 10% for β-(1,3)-D-
glucan. These samples were assigned half of the LOD
value [23]. Data were presented as loads equivalent to
endotoxin units (EU) per m2 (EU/m2) and β-(1,3)-D-
glucan in µg per m2 (µg/m2).
qPCR assays were prepared using SYBR Green
Master Mix (Bio-Rad Laboratories Inc., California,
USA). DNA from the following microorganisms was
detected using primers for (1) one group of bacteria
(Streptomyces spp.), (2) 15 fungal species (Acremonium
strictum, Alternaria alternata, Aspergillus fumigatus,
Aspergillus versicolor, Aspergillus niger, Chaetomium
globosum, Cladosporium cladosporioides, Cladosporium
herbarum, Cladosporium sphaerospermum, Penicillium
chrysogenum, Rhizopus stolonifer, Stachybotrys char-
tarum/chlorohalonata, Trichoderma viride, Ulocladium
chartarum, Wallemia sebi), (3) three fungal groups
(Mucor/Rhizopus spp., Aspergillus glaucus spp.,
Penicillium/Aspergillus/-Paecilomyces variotiii spp.),
and (4) one universal fungal primer for the total fungal
load. Standard curves were produced for respective
analysis based on total genomic DNA extracts from
pure cultures and were quantified using limiting dilu-
tion analysis [24]. Microorganisms were calculated at
cell level, expressing results as cell equivalents (CE) per
m2 (CE/m2) referring to the number of spores per m2.
Outcome assessment
Atopy and allergy
Skin-prick-testing (SPT) to a standard panel of 10
aeroallergens was performed by a trained nurse using
the Soluprick SQ system (ALK Abelló A/S, Hørsholm,
Figure 1. Study design and selection of participants.
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Denmark) and included the allergen extracts: (1) pol-
len: birch (Betula verrucosa), grass (Phleum pratense)
and mugwort (Artemisia vulgaris); (2) pets: cat (Felis
domesticus), dog (Canis familiaris), and horse (Equus
caballus); (3) two house dust mites (dermatophagoides
pteronyssinus and Dermatophagoides farina); and (4)
two moulds (Cladosporium herbarum and Alternaria
alternata). Histamine chloride was used as positive
control and saline as negative control. Atopy was
defined by having a positive test (mean wheal of 3
mm or more after subtraction of the negative control)
to at least 1 of the 10 allergens. Participants were asked
to abstain from use of antihistamines 3 days before the
test. Allergic conditions (eczema and rhinitis) were
identified by self-reported doctor diagnosis: Has a doc-
tor ever told you that you have eczema? and Has a
doctor ever told you that you have rhinitis?
Asthma
Asthma was determined by a positive response to each
of the following four yes/no-questions: (1) Has a doctor
ever told you that you have asthma? (doctor-diagnosed
asthma); (2) Have you ever had asthma? (self-reported
asthma); (3) Do you currently use asthma medication?
(asthma medication use); and (4) Have you had wheez-
ing or whistling in your chest at any time? (wheeze, the
last 12 months) [25].
Lung function
Lung function was measured by spirometry according to
American Thoracic Society/European Respiratory Society
(ATS/ERS) guidelines [26] using Spiro USB Spirometers
(MicroMedical Limited, Rochester, Kent, UK) [25].
Spirometers were checked daily with a 3-l calibrated syr-
inge, and checked every 6 months with a decompression
Figure 2. Associations of moisture damage with allergy, asthma and lung function in the random sample, atopics and non-atopics.
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flow simulator [27]. Lung function data were obtained for
99% of the participants. Information on participant’s sex,
age, height, forced expiratory volume in first second
(FEV1) and forced volume capacity (FVC) were applied
to calculate z-scores of FEV1, FVC and the FEV1/FVC-
ratio based on the Global Lung Function Initiative (GLI)
spirometry equations [28].
Statistical analyses
Initial analyses described basic-, indoor environmental-,
and health characteristics. Chi-squared tests and t-tests
were used to assess differences between atopic and non-
atopic participants. Microbial loads (per m2 of sampling
area) followed a lognormal distribution and were pre-
sented as geometric means (GM) with geometric stan-
dard deviations (GSD). Differences in microbial exposure
between bedrooms of atopics, non-atopics and the ran-
dom sample were assessed by t-tests.
Multiple logistic regression analyses were conducted to
assess associations between dampness indicators and
microbial exposures and allergy and asthma outcomes.
Multiple linear regression analyses were used to assess
associations with lung function. In addition to specific
microbial markers, we also measured associations with
the total fungal load and microbial diversity calculated as
the number of different detected fungi (excluding the fun-
gal group of Penicillium/Aspergillus/Paecilomyces varioti
spp.) and Streptomyces spp. (range, n = 1–18). All regres-
sion analyses were adjusted for sex, age, smoking, hours
spent in the home, season, and additionally in sensitivity
analyses for crowding (occupants perm2), type of dwelling,
indoor area (m2), and pet keeping. Confounders were
chosen a priori on the basis of previous evidence or poster-
iori due to differences in their association with selected
groups. Multivariate results are presented as odds ratios
(OR) for airway symptoms, doctor-diagnosed asthma, and
allergy and as β-coefficients for lung function parameters,
both with 95% confidence intervals (95%CI). TheORs and
β-coefficients represent the estimated health effect
expressed as the change associated with an increase in
unit of load of microbial exposures, total fungal load,
diversity or presence versus absence of dampness indica-
tors. A significance level of p < 0.05 was applied. Statistical
analyses were conducted using Stata version 13 (StataCorp
LP, College Station, Texas, USA).
Results
Characteristics of the study population
Significant differences in characteristics between the study
groups were found (Table 1). The atopic and non-atopic
groups differed from the random sample on several char-
acteristics: they were younger (due to the age-based selec-
tion), spent less time at home, had a larger living area, had
more co-habitants, were more likely to keep pets, and were
more likely to report condensation on windows. Generally,
the atopic and non-atopic groups were similar in charac-
teristics, but the atopic group was significantly more likely
to report presence of condensation on windows and live in
smaller homes. Sensitization against pollen allergens was
most prevalent followed by pet- and house dust mite
allergens (Table 2). Atopics were significantly more likely
to report rhinitis, eczema, doctor-diagnosed asthma, self-
reported asthma, and wheezing compared to non-atopics
and to the random sample. Lung function was lower in
atopic participants than in the random sample and non-
atopic group, when taking into account age, sex, height and
ethnicity shown in the z-scores.
Prevalence and diversity of microbial exposure
The most common microbes found in the dust were:
Aspergillus versicolor, Penicillium/Aspergillus/Paecilomyces
varioti spp., Cladosporium spp., Streptomyces spp., and
Wallemia sebi (Table S1 (supplementary material)).
Microbial loads varied greatly between homes, although
at least three of themicroorganisms were quantifiable in all
samples (mean, 7; SD, 2.71). Significant seasonal variation
was seen for several microorganisms. Cladosporium spp.,
Alternaria alternata and the total fungal load were highest
during warm months (summer) and lowest during winter
months, and Penicillium spp. and Aspergillus spp. was the
opposite. Additionally, microbial diversity was lowest dur-
ing winter (Table S2). On average, dust sampled from
homes of atopics contained significantly less Aspergillus
fumigatus, Cladosporium sphaerospermum, Penicillium/
Aspergillus/Paecilomyces varioti spp., Penicillium chryso-
genum, Stachybotrys chartarum/chlorohalonata than dust
from homes of non-atopics (Table 3). Significantly less
endotoxin and Penicillium/Aspergillus/Paecilomyces varioti
spp. were found in dust samples from homes of atopics
compared to the random sample. Significantly less
Acremonium strictum, Aspergillus fumigatus,
Cladosporium herbarum, Cladosporium sphaerospermum,
Penicillium chrysogenum, Stachybotrys chartarum/chloro-
halonata, but more endotoxin was found in dust from the
households in the random sample, and the dust was less
diverse in microbial composition than the dust sampled in
the homes of non-atopics. Generally, positive but weak
correlations were found between groups of microorgan-
isms (r < 0.50), but subgroups of Cladosporium spp. were
moderately to highly correlated (r = 0.72 to 0.88), as were
Cladosporium spp. and total fungi (r = 0.76 to 0.83) (Table
S3).Microbial diversity was significantly but only weakly to
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moderately correlated with the individual microorganisms
(r = 0.18 to 0.73). Few significant differences were found in
microbial loads or indicators between homes with and
without visible damp stains, mould odor, condensation
on windows and moisture damage (Table S4). Among
these, a higher load of endotoxin was detected for partici-
pant’s reporting having mold odor indoors, whereas the
load of endotoxin was lower among participant’s reporting
having damp stains in their bedroom.
Household dampness, allergy, asthma and lung
function
Self-reported mould odor was positively associated with
wheezing in atopics (OR 6.05; 95%CI 1.19 to 30.7)
(Table S5). Additionally, moisture damage was associated
with increased doctor-diagnosed asthma, self-reported
asthma, and wheeze, although this was only statistical
significant for self-reported asthma in atopics (OR 3.52;
95%CI 1.01 to 12.7) (Figure 2). When performing an
overall analysis focusing on a potential interaction
between dampness indicators and atopy on asthma out-
comes, interaction was not found neither with mould
odor (p = 0.44) nor with moisture damage (p = 0.15).
No statistical significant associations were observed
between dampness indicators and lung function and
allergic diseases other than asthma, except for a lower
zFVC in non-atopics reporting mould odor (β-coeff.
−0.04; 95%CI −0.07 to −0.01).
Microbial exposure, allergy, asthma and lung function
Associations between microbial exposure and allergy,
asthma and lung function are shown in supplementary
Table 1. Characteristics of the study population.
Random sample Atopics Non-atopics
n (%) n (%) n (%) p-value
Basic characteristics
Number of participants 196 (100) 107 (100) 99 (100) -
Sex
Male 94 (48) 42 (40) 42 (42) 0.64a
Female 102 (52) 65 (60) 57 (58)
Age (year), mean (SD) 54 (12.6) 42 (5.19) 44 (5.47) 0.21b
20-29 years 7 (4) 0 (0) 0 (0)
30-39 years 18 (9) 32 (30) 26 (26)
40-49 years 49 (25) 75 (70) 73 (74)
50-59 years 43 (22) 0 (0) 0 (0)
60-69 years 59 (30) 0 (0) 0 (0)
>70 years 20 (10) 0 (0) 0 (0)
Home characteristics
Hours spend in the home, mean (SD) 14.6 (4.7) 12,8 (3.2) 13,1 (2.9) 0.59b
Type of dwelling
Apartment 49 (25) 26 (24) 22 (22) 0.35a
Detached house 107 (55) 62 (58) 61 (62)
Attached house/Rowhouse 39 (19) 18 (17) 15 (15)
Other type of dwelling 1 (1) 1 (1) 1 (1)
Indoor area (m2) 126 (45.8) 122 (39.3) 137 (61.5) 0.04b
<70 m2 15 (8) 10 (10) 6 (6) 0.68a
70-110 m2 68 (35) 30 (28) 29 (30)
>110 m2 113 (57) 68 (62) 64 (64)
Number of occupants 2,3 (1.01) 3,3 (1.25) 3,3 (1.18) 0.84b
1 31 (16) 12 (11) 10 (10) 0.40a
2 114 (58) 18 (18) 14 (14)
3 20 (10) 16 (15) 24 (25)
4 24 (12) 47 (44) 37 (38)
≥5 7 (4) 14 (12) 13 (13)
Crowding, mean (SD) 0.02 (0.01) 0,03 (0.01) 0,03 (0.01) 0.30b
Pet keeping (yes) 62 (32) 48 (45) 55 (56) 0.12a
Smoking, current (yes) 18 (9) 17 (16) 16 (16) 0.95a
Daily 13 (7) 12 (11) 10 (10) 0.30a
Occasionally 5 (3) 5 (5) 6 (6)
Ex-smoker 51 (26) 32 (30) 41 (41)
Never smoker 126 (64) 58 (55) 42 (42)
Dampness indicators
Damp stains in bedroom (yes) 12 (6) 12 (12) 8 (8) 0.45a
Mould odor (yes) 5 (3) 9 (8) 2 (2) 0.38a
Condensation on windows (yes) 48 (25) 43 (40) 34 (34) 0.04a
Moisture damage, ever (yes) 47 (27) 23 (25) 27 (29) 0.85a
Definition of abbreviations: n denotes number, SD denotes standard deviation. Statistical significance between atopics and non-atopics is denoted by a
p-value <0.05.
aChi2-test.
bt-test.
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information (Table S6-S8). For microbial components,
higher loads of β-(1,3)-D-glucan and endotoxin tended
to be associated with poorer health outcomes in terms
of allergy, asthma and lung function, although only the
association of endotoxin with self-reported asthma was
statistically significant in the random sample (β-coeff.
1.71; 95%CI 1.05 to 2.78).
Analyses of individual species or groups of microorgan-
isms showed generally inconsistent associations, and few of
these associations were significant. In the random sample,
inverse associations were statistically significant between
Streptomyces spp., Aspergillus versicolor, Cladosporium
sphaerospermum and rhinitis, and additionally between
Cladosporium herbarum and eczema (Table S6).
Furthermore, positive associations were shown for
Trichoderma viride and rhinitis in both the random sample
and in the non-atopic group, and also between
Chaetommium globosum and rhinitis in the non-atopic
group. In terms of respiratory outcomes, inverse associa-
tions were found for Penicillium/Aspergillus/Paecilomyces
varioti spp. with doctor-diagnosed asthma and for
Aspergillus fumigatus and Cladosporium sphaerospermum
with self-reported asthma in non-atopics (Table S7).
Moreover, positive associations were found between
Trichoderma viride and self-reported asthma in non-ato-
pics and between Acremonium strictum and wheezing in
atopics. For lung function outcomes, a pattern of positive
associations of species and groups of microorganisms with
zFEV1/FVC-ratio were shown in non-atopics, being statis-
tical significant only for Streptomyces spp., Aspergillus ver-
sicolor, Chaetommium globosum, Penicillium/Aspergillus/
Paecilomyces varioti spp. andWallemia sebi (Table S8). In
contrast, in the random sample inverse associations were
found for Alternaria alternata, Cladosporium cladospor-
ioides, Cladosporium herbarum with zFEV1/FVC-ratio
and for Aspergillus niger with zFVC, and in the atopics
for Chaetommium globosum with zFEV1.
Regarding microbial diversity and total fungal load,
an overall pattern was observed with increasing diversity
of microorganisms associated with a lower prevalence of
rhinitis and asthma outcomes (Figure 3). This was, how-
ever, only significant among the random sample for
rhinitis (OR 0.79; 95% CI 0.64 to 0.97) and in non-
atopics for doctor-diagnosed asthma (OR 0.72; 95%CI
0.54 to 0.96), self-reported asthma (OR 0.78; 95%CI 0.61
to 0.98) and a higher zFEV1/FVC-ratio (β-coeff. 0.09;
95%CI 0.03 to 0.16). Similarly, inverse associations
were found for total fungi and eczema (OR 0.48; 95%
CI 0.23 to 0.96) and zFEV1/FVC-ratio (β-coeff. −0.12;
95%CI −0.24 to −0.01) in the random sample. Total
fungi were associated with a higher zFEV1/FVC-ratio
(β-coeff. 0.17; 95%CI 0.01 to 0.32) in the non-atopics.
When testing for interaction, we observed neither an
increased nor decreased effect of diversity on the
above-mentioned outcomes in relation to atopic status
(results not shown). Furthermore, to increase power, we
Table 2. Allergy, asthma and lung function in the random sample, atopics and non-atopics.
Random sample Atopics Non-atopics
N = 196 N = 107 N = 99
n (%) n (%) n (%) p-value
Allergy
SPT, any positive 64 (33) 107 (100) 0 (0) 0.00a
Pollen 49 (25) 84 (78) 0 (0) 0.00a
Pets 27 (14) 52 (48) 0 (0) 0.00a
Molds 4 (2) 10 (9) 0 (0) 0.01a
House dust mites 21 (11) 44 (41) 0 (0) 0.00a
Rhinitis 33 (17) 57 (53) 5 (5) 0.00a
Eczema 3 (2) 10 (9) 4 (4) 0.01a
Asthma
Doctor-diagnosed asthma 14 (7) 21 (20) 10 (10) 0.02a
Self-reported asthma 16 (8) 22 (21) 11 (11) 0.03a
Asthma medication 8 (4) 9 (8) 4 (4) 0.92a
Wheeze 19 (10) 24 (22) 10 (10) 0.01a
Lung function
Observed
FEV1 (l), mean (SD) 3.08 0.82 3.37 0.69 3.45 0.82 0.01
b
FVC (l), mean (SD) 4.01 1.03 4.31 0.92 4.45 0.99 0.03b
FEV1/FCV (%), mean (SD) 0.77 0.07 0.79 0.06 0.77 0.06 0.01
b
z-scores
zFEV1, mean (SD) −0.34 0.94 −0.49 0.75 −0.37 0.99 0.03
b
zFVC, mean (SD) −0.19 0.92 −0.28 0.75 −0.11 0.84 0.05b
zFEV1/zFCV, mean (SD) −0.31 0.95 −0.37 0.92 −0.48 0.97 0.81
b
Definition of abbreviations: n, number; SD, standard deviation; SPT, skin prick test (atopic sensitisation); FEV1, forced expiratory volume in first sec.; FVC, forced
vital capacity; zFEV1, z-score for FEV1; zFVC, z-score for FVC; zFEV1/FVC, z-score for the ratio between FEV1 and FVC. Statistical significance between atopics
and non-atopics is denoted by p-value <0.05.
aChi2-test.
bt-test.
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pooled all participants and performed analyses on micro-
organisms (individual species or groups of microorgan-
isms, the total fungal load and diversity) with health
outcomes while adjusting for atopy showing similar
overall inconsistency in associations (data not shown).
Discussion and conclusion
To our knowledge, this is the first study to examine
diverse domestic microbial exposures based on micro-
bial DNA analysis of household dust and the associated
allergic and respiratory health in adults. Self-reported
household moisture damage was positively associated
with asthma outcomes, and mould odor with wheezing
in atopics. Inconsistent associations were found for
individual microbial exposures and health outcomes,
but we observed inverse associations between some
microorganisms and doctor-diagnosed- and self-
reported asthma in the non-atopics. Furthermore, our
findings suggest that higher microbial diversity may be
associated with less rhinitis and asthma, although this
reached statistically significant for only some of the
observed associations.
Among the other findings in our study, higher loads of
β-(1,3)-D-glucan and endotoxin were associated with
poorer health outcomes. This has previously been observed
with β-(1,3)-D-glucan and airway obstruction [29] and
airway inflammation in adults [29,30], as well as respira-
tory symptoms and peak expiratory flow variability in
children [31–34]. Endotoxin induces airway inflammation
and can cause and exacerbate respiratory symptoms in
high doses. However, at lower doses, the epidemiological
findings on respiratory symptoms, asthma and allergy are
conflicting as positive, as well as negative and no associa-
tions have been reported in both children and
adults [5,6,35,36]. Despite these inconsistencies, the epide-
miological evidence indicates that in general, increased
endotoxin levels may be associated with a lower risk of
atopic sensitization, hay fever and atopic asthma, but a
higher risk of respiratory symptoms [37–40].
In accordance with our findings in adults, only few
significant associations have previously been reported
between individual microbes and respiratory health in
children [9,12,41]. A similar inverse association was
observed between higher amounts of Aspergillus fumi-
gatus/Neosartorya fischeri spp., Cladosporium spp. and
having less asthma and/or wheeze in a study that
included additional microbial spp. compared to our
study [41]. In contrast to our findings, a positive asso-
ciation has been reported between Streptomyces DNA
and doctor-diagnosed asthma [9] and an inverse asso-
ciation with FEV1 [12]. Moreover, a case–control study
found that Aspergillus versicolor DNA levels were
slightly elevated in homes of allergic persons compared
Figure 3. Associations of microbial diversity and total fungi with allergy, asthma and lung function in the random sample, atopics
and non-atopics.
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with homes of non-allergic persons’ homes [14]. Also
in homes of atopic children with mild and severe
asthma, fungal exposure differed significantly in one
study [42]. Due to the currently limited and inconsis-
tent findings on the health effects of microbial expo-
sure measured by microbial DNA, further investigation
preferably based on a prospective design with repeated
measurements is required in order to validate the cur-
rent findings.
When comparing the present study to previous studies
using similar methods for dust sampling and analysis, we
found lower endotoxin loads [22,43,44], and lower β-
(1,3)-D-glucan loads [19,45]. The reason for this is
unknown but is likely to be attributed to methodological
differences between studies [46]. Furthermore, in regards
to our exposure assessment, the diversity score should be
considered as a crude estimate of the overall microbial
diversity and essentially only show fungal diversity as
only one bacterial species (Streptomyces spp.) was
included. Our findings indicate that increased microbial
diversity may be associated with reduced allergy and
respiratory outcomes in adults. A protective association
of microbial diversity has also been shown previously
with asthma [18,42] and wheeze [41] in children.
Similarly, another study in asthmatic children showed
that fungal concentration and composition was asso-
ciated with increased risk of severe asthma, but in con-
trast low bacterial richness was associated with reduced
risk of severe asthma [47]. Our findings indicate that the
protective effect of a diverse microbial environment may
also apply to non-farming environments, and to adults,
rather than children. However, no conclusions on the
potential mechanisms underlying this protective effect
can be derived from the current cross-sectional study.
The design allows us to establish only associations rather
than causal relationships. Furthermore, we have only
sampled dust once at single point in time. Health effects
depend on prior, not subsequent or posterior exposures
and therefore, we may not have measured exposures at
the time most relevant for the investigated health out-
comes. Additionally, we were unable to fully elucidate the
association of total fungal load and specific microbial
exposures due to the correlations between species.
Nonetheless, our findings indicate that microbial diver-
sity may be associated with allergy and respiratory health
after adjustment for essential confounders. Further long-
itudinal investigation of indoor environmental dynamics
and the associations between the indoor microbial flora
and occupants’ respiratory health are required to better
identify the specific causal agents. An additional limita-
tion of this study is that we performed multiple testing,
increasing the risk of false-positive associations.
Therefore, as this is a relatively small study with a large
number of test performed, the observed associations
should be considered as suggestive.
In contrast to the associations observed between
moisture damage and asthma and mould and wheeze in
atopics, no such associations were found in the non-
atopics. However, due to the low prevalence of dampness
problems in non-atopics, we were unable to evaluate
whether atopics may be more susceptible to household
dampness than non-atopics. Moreover, we cannot rule
out that the observed associations in the atopics are
occurring due to reporting bias as people reporting
adverse health outcomes may be more likely to report
dampness. The use of observations made by the investi-
gators rather than the participants would be preferable.
Moreover, the use of a prospective design is more desir-
able for temporal separation of exposure and outcome
assessment. This design was applied in the European
Community Respiratory Health Survey (ECRHS) com-
prising 7,104 adults from 13 countries, that showed an
increased risk of new-onset asthma with water damage
(RR, 1.46; 95% CI, 1.09 to 1.94) and with mould odor
(RR, 1.30; 95% CI, 1.00 to 1.68) reported at baseline [1].
Additionally, in the ECHRS study, a stronger health effect
of household dampness was observed in atopics com-
pared with non-atopics [1], similar to our findings of an
effect in atopics.
A strength of our study is the inclusion of lung func-
tion, which is a more objective measure than self-
reported symptoms. However, we found no decline in
lung function associated with dampness despite the fact
that it has been observed in other studies [8,48,49] and no
clear or consistent associations were found between spe-
cies and groups of microorganisms and lung function.
Furthermore, we were unable to identify potential micro-
bial agents responsible for the observed association
between dampness indicators and asthma, since we
found only a few significant associations between indivi-
dual microbial exposures and dampness indicators. It
should, however, be noted that due to the low prevalence
of some dampness indicators, we were underpowered to
show any difference in levels of microbial exposure.
In conclusion, household moisture damage was
associated with increased risk of asthma and mould
odor with an increased risk of wheeze in atopics.
Moreover, our findings suggest that asthma and allergy
in adults may, in some cases, be associated with species
composition and microbial load present in urban
domestic environments.
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